Clinicians debate antiretroviral tactics and toxicities, resistance testing, and hepatitis virus coinfection. IAPAC sessions 2002 - May 16-17, 2002.
Mascolini
Mark
M
D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006509:Hepatitis B / Q000150:complications* / Q000188:drug therapy; D006526:Hepatitis C / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D011786:Quality Control; D014481:United States
D019380:Anti-HIV Agents